Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-14, with 60 holding rows worth $208,933,000.

Accession
0001697013-18-000004
Filed
2018-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 61 entries on the cover page, a total value of $208,933,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $208,933,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUALITY CARE PPTYS INC747545101COM1,030,661$20,026,000thousands by filing date
R1 RCM INC749397105COM1,909,887$13,637,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW333,738$11,995,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM210,778$11,435,000thousands by filing date
ABLYNX NV00372Y105SPONSORED ADR181,891$9,924,000thousands by filing date
SPDR S&P 500 ETF TR78462F953PUT600$9,735,000thousands by filing dateput
AVEXIS INC05366U100COM78,201$9,664,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock78,893$9,396,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR226,584$8,948,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW220,788$8,721,000thousands by filing date
ENSIGN GROUP INC29358P101COM325,897$8,585,000thousands by filing date
ZOGENIX INC.98978L204Common Stock204,546$8,192,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM44,822$7,305,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock357,727$5,838,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR137,972$5,530,000thousands by filing date
NEVRO CORP64157F103COM60,850$5,274,000thousands by filing date
TELIGENT INC NEW87960W104COM1,550,383$5,209,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM24,000$3,866,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM46,000$3,729,000thousands by filing date
TESARO INC881569107COM51,523$2,944,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR35,784$2,878,000thousands by filing date
Abbott Laboratories002824100COM47,900$2,870,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock150,000$2,130,000thousands by filing date
ABIOMED INC003654100COM7,094$2,064,000thousands by filing date
MYOKARDIA INC62857M105COM42,000$2,050,000thousands by filing date
INVACARE CORP461203101COMMON STOCK99,902$1,738,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM85,090$1,705,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR24,054$1,573,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK22,924$1,560,000thousands by filing date
CARETRUST REIT INC COM14174T107REIT108,264$1,473,000thousands by filing date
Elevance Health, Inc.036752103COM6,000$1,318,000thousands by filing date
MEDICINES CO584688105COM39,317$1,295,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM65,000$1,099,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock14,646$1,072,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock10,000$1,069,000thousands by filing date
EHEALTH INC28238P109COM74,546$1,067,000thousands by filing date
EPIZYME INC29428V104COM57,449$1,020,000thousands by filing date
MAGELLAN HEALTH SERVICES INC559079207COM NEW9,282$994,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM17,800$860,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock3,000$753,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW250,000$753,000thousands by filing date
IRADIMED CORP46266A109COMMON STOCK51,059$735,000thousands by filing date
AFFIMED N VN01045108COM386,862$716,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock148,959$711,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW30,000$596,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value117,495$587,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK18,029$587,000thousands by filing date
MELINTA THERAPEUTICS INC58549G100COM76,837$569,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS107,500$551,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW209$547,000thousands by filing datecall
AQUINOX PHARMACEUTICALS INC03842B101COM31,987$450,000thousands by filing date
OPHTHOTECH CORP683745103COM149,100$409,000thousands by filing date
ENVISION HEALTHCARE CORP29414D100COM9,520$366,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM30,899$313,000thousands by filing date
AXOGEN INC05463X106COM5,000$183,000thousands by filing date
DERMIRA INC24983L104COM20,018$160,000thousands by filing date
MIMEDX GROUP INC602496101COM480$103,000thousands by filing datecall
QUOTIENT LTDG73268107SHS10,511$50,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM22$4,000thousands by filing dateput
CELGENE CORP151020112RIGHT 12/31/20306,000$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-18-000004this filing2018-05-14acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000007 base2023-11-08acceptance time not in the bulk data set